LDL-C lowering in patients treated with bempedoic acid in a real-world cohort.

Saved in:
Bibliographic Details
Title: LDL-C lowering in patients treated with bempedoic acid in a real-world cohort.
Authors: Nelson J; Veradigm, Chicago, IL, USA., Bloedon L; Esperion Therapeutics, Inc., Ann Arbor, MI, USA., Lewandowski D; Veradigm, Chicago, IL, USA., Vaduganathan M; Brigham and Women's Hospital Heart and Vascular Center, Boston, MA, USA., Ajose M; Veradigm, Chicago, IL, USA., Bonafede M; Veradigm, Chicago, IL, USA., Sarnes E; Esperion Therapeutics, Inc., Ann Arbor, MI, USA.
Source: Atherosclerosis plus [Atheroscler Plus] 2026 Feb 04; Vol. 63, pp. 58-66. Date of Electronic Publication: 2026 Feb 04 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9918249514806676 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-0895 (Electronic) Linking ISSN: 26670895 NLM ISO Abbreviation: Atheroscler Plus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2667-0895
DOI:10.1016/j.athplu.2026.01.007